Efficacy and safety of recently approved drugs for sickle cell disease: A review of clinical trials
Sickle cell disease is prevalent in several parts of the world. Most of the hospitalizations in these patients are related to pain crisis episodes. Moreover, the levels of hemoglobin are lower in sickle cell disease patients as compared to the general population. Complications related to sickle cell...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12354
- Acceso en línea:
- https://doi.org/10.1016/j.exphem.2020.08.008
http://hdl.handle.net/20.500.12010/12354
- Palabra clave:
- Sickle cell disease
Glutamine
Voxelotor
Crizanlizumab
Efficacy
Safety
Clinical trials
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Acceso restringido